Initial Approach to Managing a Patient with an Osteolytic Lesion
The initial approach to a patient with an osteolytic lesion should include whole-body low-dose computed tomography (WB-LDCT) or PET/CT with FDG for diagnosis, followed by appropriate biopsy to confirm the etiology before initiating targeted treatment. 1
Diagnostic Workup
Imaging Studies
Initial Imaging:
Additional Imaging Based on Initial Findings:
- Whole-body MRI (WB-MRI) when previous findings are inconclusive or spinal cord compression is suspected 1
- MRI is superior for detecting bone marrow infiltration before cortical destruction 2
- Technetium bone scanning to detect skip metastases and distant spread 2
- CT scan of the thorax to detect lung metastases not visible on chest X-ray 2
Laboratory Assessment
- Complete blood count
- Serum calcium levels
- Alkaline phosphatase and LDH levels 2
- Renal function tests 2
- Urinary N-methylhistamine and prostaglandin metabolites if systemic mastocytosis is suspected 2
Biopsy
- CT-guided biopsy of suspicious area(s) is strongly recommended, especially in bone-only disease or when imaging is equivocal 2
- Biopsy should be performed by the surgeon who will eventually do the definitive surgery 2
- The biopsy incision must be placed in an area that will be excised during eventual resection 2
- Pathological assessment by a specialist familiar with bone tissue is crucial 2
Differential Diagnosis
Osteolytic lesions can be caused by various conditions:
Malignant Conditions:
- Multiple myeloma (most common cause of multiple osteolytic lesions)
- Metastatic cancer (breast, lung, kidney, thyroid)
- Primary bone tumors (osteosarcoma)
- Leukemia (rare presentation) 3
Benign Conditions:
Infectious Causes:
Metabolic Disorders:
- Hyperparathyroidism
- Paget's disease 7
Treatment Approach
Treatment should be tailored based on the underlying cause:
For Malignant Lesions
Multiple Myeloma:
Metastatic Disease:
For Spinal Lesions
Without Neurological Compromise:
With Neurological Compromise:
For Pathological Fractures
- Appendicular Skeleton:
Special Considerations
Monitoring Response to Treatment
- FDG-PET-CT is the most accurate way of assessing treatment response for hypermetabolic bone metastases 2
- Sclerosis of lytic metastases with no radiological evidence of new lesions constitutes tumor regression 2
- Be aware of the flare phenomenon on bone scans during healing, which may initially appear as progression 2
Complications to Watch For
- Cement leakage during cementoplasty (rare but potentially serious) 1
- Fractures adjacent to treated vertebrae, especially in patients with severe osteoporosis 1
- Infection in patients with fever or elevated inflammatory parameters 1
Pitfalls to Avoid
- Do not rely solely on conventional radiography for diagnosis, as it has low sensitivity 2
- Do not perform biopsy before MRI and bone scan to avoid artifacts from hemorrhage, edema, and bone healing 2
- Do not assume all osteolytic lesions are malignant; consider benign causes and infections in the differential diagnosis 5, 6
- Do not delay treatment of spinal lesions with neurological symptoms, as this can lead to permanent neurological damage 2